BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26713367)

  • 21. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
    Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation.
    Kuo PL; Shen KH; Hung SH; Hsu YL
    Carcinogenesis; 2012 Dec; 33(12):2477-87. PubMed ID: 23027620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
    Deeb D; Gao X; Dulchavsky SA; Gautam SC
    J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells.
    Lau MT; Leung PC
    Cancer Lett; 2012 Dec; 326(2):191-8. PubMed ID: 22922215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway.
    Saegusa M; Hashimura M; Suzuki E; Yoshida T; Kuwata T
    Am J Pathol; 2012 Aug; 181(2):684-92. PubMed ID: 22698986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
    Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
    Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyphyllin E Inhibits Proliferation, Migration and Invasion of Ovarian Cancer Cells by Down-Regulating the AKT/NF-κB Pathway.
    Liu Y; Cao Y; Kai H; Han Y; Huang M; Gao L; Qiao H
    Biol Pharm Bull; 2022 May; 45(5):561-568. PubMed ID: 35185080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway.
    Song G; Cai QF; Mao YB; Ming YL; Bao SD; Ouyang GL
    Cancer Sci; 2008 Oct; 99(10):1901-7. PubMed ID: 19016748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DDX10 promotes the proliferation and metastasis of colorectal cancer cells via splicing RPL35.
    Zhou X; Liu Z; He T; Zhang C; Jiang M; Jin Y; Wu Z; Gu C; Zhang W; Yang X
    Cancer Cell Int; 2022 Feb; 22(1):58. PubMed ID: 35109823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant epigenetic alteration in Eca9706 cells modulated by nanoliposomal quercetin combined with butyrate mediated via epigenetic-NF-κB signaling.
    Zheng NG; Wang JL; Yang SL; Wu JL
    Asian Pac J Cancer Prev; 2014; 15(11):4539-43. PubMed ID: 24969881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cadherin protein CDH19 mediates cervical carcinoma progression by regulating AKT/NF-κB signaling.
    Yu J; Sun X; Yu Y; Cui X
    Acta Biochim Pol; 2023 Dec; 70(4):955-961. PubMed ID: 38052007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT7 Exhibits Oncogenic Potential in Human Ovarian Cancer Cells.
    Wang HL; Lu RQ; Xie SH; Zheng H; Wen XM; Gao X; Guo L
    Asian Pac J Cancer Prev; 2015; 16(8):3573-7. PubMed ID: 25921180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells.
    Wen F; Wu ZY; Nie L; Zhang QZ; Qin YK; Zhou ZL; Wu JJ; Zhao X; Tan J; Sawmiller D; Zi D
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31316002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of HHLA2 inhibits ovarian cancer progression via the NF-κB signaling pathway and suppresses the expression of CA9.
    Fu Y; Zheng P; Zheng X; Chen L; Kong C; Liu W; Li S; Jiang J
    Cell Immunol; 2023 Jul; 388-389():104730. PubMed ID: 37210768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway.
    Zhang MH; Zhang HH; Du XH; Gao J; Li C; Shi HR; Li SZ
    Oncogene; 2020 Jan; 39(2):322-333. PubMed ID: 31477831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.